Cerebral transthyretin-associated amyloidoses

A.Prof Frank Gaillard et al.

Cerebral involvement can be seen transthyretin-associated amyloidoses and presents as a neurodegenerative disease

Age of presentation is very wide, ranging from adolescence to old age 1

Clinical presentation is variable, but includes 1:

The diagnosis is often not made during life, unless specific gene testing is performed, once the diagnosis is suspected. 

Cerebral transthyretin-associated amyloidoses have been linked to a rare mutation of the transthyretin gene (chromosome 18q11.2-12.1), the product of which is a transport protein by the same name, responsible for transport of thyroxin-binding and retinol-binding peptides. Dysfunction of transthyretin results in accumulation of these peptides and the formation of amyloid deposits 1

Unfortunately, no specific features exist, and appearances are those of cerebral amyloid angiopathy (CAA) 1. Features therefore include:

Neurodegenerative diseases

Neurodegenerative diseases are legion and their classification just as protean. A useful approach is to divide them according to underlying pathological process, although even using this schema, there is much overlap and thus resulting confusion.

Share article

Article information

rID: 13057
Synonyms or Alternate Spellings:
  • Transthyretine associated cerebral amyloidoses
  • Transthyretine associated cerebral amyloidosis
  • Cerebral transthyretin-associated amyloidosis

Support Radiopaedia and see fewer ads

Updating… Please wait.

Alert accept

Error Unable to process the form. Check for errors and try again.

Alert accept Thank you for updating your details.